Please login to the form below

Not currently logged in
Email:
Password:

clinical data

This page shows the latest clinical data news and features for those working in and with pharma, biotech and healthcare.

Akcea steals march on Alnylam with NICE approval

Akcea steals march on Alnylam with NICE approval

This is vital for Tegsedi, which had generally been seen as the runner-up to Onpattro in terms of the data produced in their pivotal clinical trials.

Latest news

  • Sangamo surges on data for haemophilia A gene therapy Sangamo surges on data for haemophilia A gene therapy

    the wake of the announcement of data from just eight patients in a phase 1/2 trial. ... The new data would seem to put SB-525 firmly in contention with two other haemophilia A gene therapies that have been generating clinical data, namely valoctocogene

  • Pfizer hedges bets on gene therapy deal Pfizer hedges bets on gene therapy deal

    Pfizer will pay 45m ($51m) upfront to the Paris-based gene therapy company, plus up to 560m ($635.8m), subject to certain clinical, regulatory, and commercial milestones. ... Pfizer can exercise its option to acquire 100% of Vivet following the

  • Roche, AbbVie hit by clinical hold for Venclexta in myeloma Roche, AbbVie hit by clinical hold for Venclexta in myeloma

    The partial clinical hold follows a review of data from the ongoing phase 3 BELLINI trial (M14-031) of the drug in relapsed/refractory multiple myeloma, according to the companies, who ... Both approaches will of course be undermined if the excess

  • Blood disorder specialists Imara raises $63m Blood disorder specialists Imara raises $63m

    It’s currently in a phase 2 clinical trial, but early data suggests the drug can improve health outcomes and possibly ameliorate disease pathology. ... Chin said: “Rahul and the growing executive team have impressed us with their focus on meaningful

  • Boehringer’s IL-36-targeting drug tackles rare form of psoriasis Boehringer’s IL-36-targeting drug tackles rare form of psoriasis

    This trial provides long-awaited clinical data that demonstrates the positive effect of blocking IL-36 action as a potential, novel treatment approach,” said Bachelez, who described the pathway as “one ... Due to its potential, we are moving to the

More from news
Approximately 0 fully matching, plus 745 partially matching documents found.

Latest Intelligence

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    Data in rare diseases is incredibly powerful.”. Sandi Deans, Consultant Clinical Scientist, GenQA/UK NEQAS. ... There are some very negative connotations about industry grabbing data and doing horrible things with it,” said Hackett.

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    The life sciences sector is unquestionably one of the UK’s most important industries: world-class research universities; strength in clinical and translational medicine in the NHS; longitudinal data sets; the ... Unlike systems such. as the US where

  • Rare Diseases Day Rare Diseases Day

    Parents and carers can also record and capture observations of patients by completing clinical assessments. ... Such systems are helping clinical teams to visualise this data, allowing them to share knowledge with other clinicians.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    The EU regulator has cleared Takhzyro (lanadelumab) for the preventive treatment of HAE in patients aged over 12, based on clinical data showing that the drug can reduce HAE attacks – typically ... It also unveiled mid-stage data on its JAK1 inhibitor

  • Why precision medicine demands precision engagement Why precision medicine demands precision engagement

    MSLs will become a valuable partner for aligning scientific information with clinical practice. ... This real-world information can help life sciences organisations understand the benefits and challenges of a treatment outside the controlled clinical

More from intelligence
Approximately 0 fully matching, plus 97 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest from PMHub

  • NHS Long Term Plan - Digital is firmly on the agenda. Are you ready?

    Clinical, genomic and other data will be linked to support the development of new treatments to improve the NHS, making data captured for care available for clinical research, and publish, as ... By harnessing industry data and utilising the latest

  • Highlights in haematologic malignancy from ASH 2018

    None is yet approved; however, the data appear to be very promising. ... The new algorithm uses patients’ genomic and clinical data to determine prognosis, outperforming the current gold standard tool for predicting survival and development of AML.

  • Artificial Intelligence in Healthcare

    Or providing never-seen-before clinical decision support, with AI scouring a vast breadth of data to return evidence-based clinical protocols. ... But, with a joined-up digital healthcare system, robust clinical data sets, and the help of AI, why can’t

  • Digital Marketing is no Substitute for Sound Strategic Marketing

    In the mid 1990’s pharmaceutical companies embraced strategic marketing to differentiate their products beyond clinical data and maintain competitive advantage. ... clinical data and always prescribed rationally.

  • Three key development areas in the management of multiple sclerosis

    Clinical trial and real-world data supporting the efficacy of disease-modifying therapies in newly diagnosed and early MS were presented at the ECTRIMS congress. ... The data showed that the majority of patients remained free from confirmed disability

More from PMHub
Approximately 1 fully matching, plus 58 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics